BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Arete Therapeutics 

3912 Trust Way

Hayward  California  94545  U.S.A.
Phone: 510-785-7060 Fax: 510-785-7061


SEARCH JOBS


Industry
Biotechnology






 Company News
Arete Therapeutics Presents Positive Clinical and Preclinical Data for AR9281 6/9/2009 9:21:34 AM    More...
Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes Phase II Study in Patients with Impaired Glucose Tolerance Designed to Confirm Therapeutic Activity 2/10/2009 10:32:27 AM    More...
Arete Therapeutics Reports Positive Phase I Data for AR9281 12/22/2008 9:55:24 AM    More...
Arete Therapeutics Closes $16.7 Million in Final Tranche of Its Series A Financing 11/19/2008 6:14:07 AM    More...
Arete Therapeutics Bolsters Management Team Appoints Euan MacIntyre, Ph.D. as Senior Vice President of Drug Discovery 10/30/2008 8:26:14 AM    More...
Arete Therapeutics Names James Sabry, M.D., Ph.D., President and Chief Executive Officer 7/8/2008 8:34:44 AM    More...
Arete Therapeutics Adds Jim Bristol as Scientific and Strategic Advisor 1/22/2008 8:07:25 AM    More...
Arete Therapeutics Appoints Donald Santel to Board of Directors 12/6/2007 11:42:01 AM    More...
Arete Therapeutics Initiates Phase 1 Clinical Trial For AR9281 as a First-in-Class Antihypertensive Agent 11/1/2007 7:22:35 AM    More...
Arete Therapeutics (Jobs) Raises $35 Million Series A 5/23/2007 10:17:05 AM    More...
12

//-->